BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27443138)

  • 1. Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments.
    Klinger JR
    Cardiol Clin; 2016 Aug; 34(3):413-33. PubMed ID: 27443138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension.
    Boucly A; Gerges C; Savale L; Jaïs X; Jevnikar M; Montani D; Sitbon O; Humbert M
    Presse Med; 2023 Sep; 52(3):104168. PubMed ID: 37516248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.
    Kalantari S; Gomberg-Maitland M
    Cardiol Clin; 2016 Aug; 34(3):443-9. PubMed ID: 27443140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.
    Khan SL; Danoff SK; Kulkarni T; Reichuber J; Shifren A; Shlobin OA; Thavarajah K; Warrior K; Case AH
    Ann Am Thorac Soc; 2024 Apr; ():. PubMed ID: 38626420
    [No Abstract]   [Full Text] [Related]  

  • 5. Future perspectives in pulmonary arterial hypertension.
    Simonneau G; Hoeper MM; McLaughlin V; Rubin L; Galiè N
    Eur Respir Rev; 2016 Dec; 25(142):381-389. PubMed ID: 27903660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in chronic lung disease and hypoxia.
    Nathan SD; Barbera JA; Gaine SP; Harari S; Martinez FJ; Olschewski H; Olsson KM; Peacock AJ; Pepke-Zaba J; Provencher S; Weissmann N; Seeger W
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension: pathogenesis and clinical management.
    Thenappan T; Ormiston ML; Ryan JJ; Archer SL
    BMJ; 2018 Mar; 360():j5492. PubMed ID: 29540357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond a single pathway: combination therapy in pulmonary arterial hypertension.
    Sitbon O; Gaine S
    Eur Respir Rev; 2016 Dec; 25(142):408-417. PubMed ID: 27903663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension due to interstitial lung disease.
    King CS; Nathan SD
    Curr Opin Pulm Med; 2019 Sep; 25(5):459-467. PubMed ID: 31365380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension in COPD: A Case Study and Review of the Literature.
    Cassady SJ; Reed RM
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31382489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    King CS; Shlobin OA
    Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
    Nathan SD; Behr J; Collard HR; Cottin V; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Boateng F; Wells AU
    Lancet Respir Med; 2019 Sep; 7(9):780-790. PubMed ID: 31416769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Simonneau G; Montani D; Celermajer DS; Denton CP; Gatzoulis MA; Krowka M; Williams PG; Souza R
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension and chronic lung disease: where are we headed?
    Elia D; Caminati A; Zompatori M; Cassandro R; Lonati C; Luisi F; Pelosi G; Provencher S; Harari S
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31636088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE DIFFICULTIES IN THE DIAGNOSIS OF PULMONARY HYPERTENSION ASSOCIATED WITH CHRONIC LUNG DISEASE.
    Łukasik S; Łukasik D; Tomaszewski M; Topyła W; Wojtowska A; Szopa A; Wysokiński A
    Wiad Lek; 2020; 73(9 cz. 1):1853-1860. PubMed ID: 33099529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in patients with interstitial lung disease.
    Karampitsakos T; Tzouvelekis A; Chrysikos S; Bouros D; Tsangaris I; Fares WH
    Pulm Pharmacol Ther; 2018 Jun; 50():38-46. PubMed ID: 29605286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Hypertension.
    Hoeper MM; Ghofrani HA; Grünig E; Klose H; Olschewski H; Rosenkranz S
    Dtsch Arztebl Int; 2017 Feb; 114(5):73-84. PubMed ID: 28241922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension.
    Dodson MW; Brown LM; Elliott CG
    Heart Fail Clin; 2018 Jul; 14(3):255-269. PubMed ID: 29966625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilation induced by PGE
    Ozen G; Benyahia C; Mani S; Boukais K; Silverstein AM; Bayles R; Nelsen AC; Castier Y; Danel C; Mal H; Clapp LH; Longrois D; Norel X
    Br J Pharmacol; 2020 Jan; 177(1):161-174. PubMed ID: 31476020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Diagnosis, and Management.
    Yandrapalli S; Tariq S; Kumar J; Aronow WS; Malekan R; Frishman WH; Lanier GM
    Cardiol Rev; 2018; 26(2):62-72. PubMed ID: 28832374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.